CagriSema (cagrilintide/semaglutide)
A combination under investigation/regulatory review. It is NOT available as a treatment: its status should be checked with the EMA/AEMPS before making any published claim.
Content reviewed by Dr. David Céspedes
This entry is for information. Your case requires an individual medical assessment.